REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-08-27

Reporting Person: POON CHRISTINE A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-27	Common Stock	M	15000	$57.11	Acquired	16681	Direct
2021-08-27	Common Stock	S	100	$662.62	Disposed	16581	Direct
2021-08-27	Common Stock	S	2260	$663.51	Disposed	14321	Direct
2021-08-27	Common Stock	S	700	$664.42	Disposed	13621	Direct
2021-08-27	Common Stock	S	538	$665.33	Disposed	13083	Direct
2021-08-27	Common Stock	S	1118	$666.7	Disposed	11965	Direct
2021-08-27	Common Stock	S	2150	$667.37	Disposed	9815	Direct
2021-08-27	Common Stock	S	603	$668.33	Disposed	9212	Direct
2021-08-27	Common Stock	S	2235	$669.59	Disposed	6977	Direct
2021-08-27	Common Stock	S	3447	$670.48	Disposed	3530	Direct
2021-08-27	Common Stock	S	1737	$671.49	Disposed	1793	Direct
2021-08-27	Common Stock	S	112	$672.27	Disposed	1681	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-27	Non-Qualified Stock Option (right to buy)	$57.11	M	15000	Disposed	2022-01-03	Common Stock (15000)	Direct

Footnotes

F1: Represents volume-weighted average price of sales of 2,260 shares of Company stock on August 27, 2021 at prices ranging from $663.11 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F2: Represents volume-weighted average price of sales of 700 shares of Company stock on August 27, 2021 at prices ranging from $664.00 to $664.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F3: Represents volume-weighted average price of sales of 538 shares of Company stock on August 27, 2021 at prices ranging from $665.07 to $665.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 1,118 shares of Company stock on August 27, 2021 at prices ranging from $666.39 to $666.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 2,150 shares of Company stock on August 27, 2021 at prices ranging from $667.01 to $667.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 603 shares of Company stock on August 27, 2021 at prices ranging from $668.04 to $668.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 2,235 shares of Company stock on August 27, 2021 at prices ranging from $669.17 to $669.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 3,447 shares of Company stock on August 27, 2021 at prices ranging from $670.01 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 1,737 shares of Company stock on August 27, 2021 at prices ranging from $671.00 to $671.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 112 shares of Company stock on August 27, 2021 at prices ranging from $672.27 to $672.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.

F11: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.